ARCHIVES

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

This article is from The Cancer Letter archive.

Vol. 30 No. 40 | October 22, 2004

Download PDF Visit The Full Archive

Related Articles

ACCC T Discuss Personnel, Fund Sources, Clinical Research At Annual Meeting

January 9, 1976

NCI Natural Product Drug Development To Get New Emphasis; Suggestions Of Critic Accepted

March 19, 1976

Ohio Plans To Build Four New Cancer Centers With $140 Million Bond Issue If Voters Approve

February 21, 1975

New Tool Found To Cut DNA At Any Position

April 4, 1986

DCE Reorganization Planned To Stem Departures, Stabilize

March 24, 1995

ACS Funds Pilot Study Of Mammography Trial

July 28, 1995